Genetics of Multidrug Resistance: Relationship of a Cloned Gene to the Complete Multidrug Resistant Phenotype

James M. Croop, Braydon C. Guild, Philippe Gros, David E. Housman

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Resistance to multiple chemotherapeutic agents remains the major cause of failure in cancer chemotherapy. Multidrug resistant cell lines developed in vitro have provided a useful model for analyzing this phenomenon. We describe a complementary DNA, λDR11, which is present in normal cells and overexpressed in multidrug resistant cell lines. We have placed this complementary DNA in an expression vector which uses the 0-actin promoter to drive transcription and introduced this vector via transfection into drug sensitive cells. Cells expressing increased levels of XDR11 are resistant to the same broad spectrum of chemotherapeutic agents which characterize the multidrug resistant phenotype. The expression of this complementary DNA in transfected clones is dependent upon the number of copies of λDR11 integrated in the genome as well as the amount of selective pressure placed on the clone during selection of the clone. Furthermore, the number of copies of λDR11 in the genome and the expression of λDR11 can be modulated by releasing an individual clone from selective pressure or by increasing the selective pressure on the clone. The endogenous sequences encoding the multidrug resistance gene are not amplified in transfected drug resistant clones. Finally, the drug resistant phenotype is reversed in the transfected clones by verapamil just as drug resistance is reversed in multidrug resistant cell lines.

Original languageEnglish (US)
Pages (from-to)5982-5988
Number of pages7
JournalCancer Research
Volume47
Issue number22
StatePublished - Jan 1 1987

Fingerprint

Multiple Drug Resistance
Clone Cells
Phenotype
Genes
Complementary DNA
Cell Line
Pharmaceutical Preparations
Genome
MDR Genes
Verapamil
Drug Resistance
Transfection
Actins
Drug Therapy
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Genetics of Multidrug Resistance : Relationship of a Cloned Gene to the Complete Multidrug Resistant Phenotype. / Croop, James M.; Guild, Braydon C.; Gros, Philippe; Housman, David E.

In: Cancer Research, Vol. 47, No. 22, 01.01.1987, p. 5982-5988.

Research output: Contribution to journalArticle

Croop, James M. ; Guild, Braydon C. ; Gros, Philippe ; Housman, David E. / Genetics of Multidrug Resistance : Relationship of a Cloned Gene to the Complete Multidrug Resistant Phenotype. In: Cancer Research. 1987 ; Vol. 47, No. 22. pp. 5982-5988.
@article{10f97201767f4224be9c8bc0d0eae5ff,
title = "Genetics of Multidrug Resistance: Relationship of a Cloned Gene to the Complete Multidrug Resistant Phenotype",
abstract = "Resistance to multiple chemotherapeutic agents remains the major cause of failure in cancer chemotherapy. Multidrug resistant cell lines developed in vitro have provided a useful model for analyzing this phenomenon. We describe a complementary DNA, λDR11, which is present in normal cells and overexpressed in multidrug resistant cell lines. We have placed this complementary DNA in an expression vector which uses the 0-actin promoter to drive transcription and introduced this vector via transfection into drug sensitive cells. Cells expressing increased levels of XDR11 are resistant to the same broad spectrum of chemotherapeutic agents which characterize the multidrug resistant phenotype. The expression of this complementary DNA in transfected clones is dependent upon the number of copies of λDR11 integrated in the genome as well as the amount of selective pressure placed on the clone during selection of the clone. Furthermore, the number of copies of λDR11 in the genome and the expression of λDR11 can be modulated by releasing an individual clone from selective pressure or by increasing the selective pressure on the clone. The endogenous sequences encoding the multidrug resistance gene are not amplified in transfected drug resistant clones. Finally, the drug resistant phenotype is reversed in the transfected clones by verapamil just as drug resistance is reversed in multidrug resistant cell lines.",
author = "Croop, {James M.} and Guild, {Braydon C.} and Philippe Gros and Housman, {David E.}",
year = "1987",
month = "1",
day = "1",
language = "English (US)",
volume = "47",
pages = "5982--5988",
journal = "Cancer Research",
issn = "0008-5472",
number = "22",

}

TY - JOUR

T1 - Genetics of Multidrug Resistance

T2 - Relationship of a Cloned Gene to the Complete Multidrug Resistant Phenotype

AU - Croop, James M.

AU - Guild, Braydon C.

AU - Gros, Philippe

AU - Housman, David E.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - Resistance to multiple chemotherapeutic agents remains the major cause of failure in cancer chemotherapy. Multidrug resistant cell lines developed in vitro have provided a useful model for analyzing this phenomenon. We describe a complementary DNA, λDR11, which is present in normal cells and overexpressed in multidrug resistant cell lines. We have placed this complementary DNA in an expression vector which uses the 0-actin promoter to drive transcription and introduced this vector via transfection into drug sensitive cells. Cells expressing increased levels of XDR11 are resistant to the same broad spectrum of chemotherapeutic agents which characterize the multidrug resistant phenotype. The expression of this complementary DNA in transfected clones is dependent upon the number of copies of λDR11 integrated in the genome as well as the amount of selective pressure placed on the clone during selection of the clone. Furthermore, the number of copies of λDR11 in the genome and the expression of λDR11 can be modulated by releasing an individual clone from selective pressure or by increasing the selective pressure on the clone. The endogenous sequences encoding the multidrug resistance gene are not amplified in transfected drug resistant clones. Finally, the drug resistant phenotype is reversed in the transfected clones by verapamil just as drug resistance is reversed in multidrug resistant cell lines.

AB - Resistance to multiple chemotherapeutic agents remains the major cause of failure in cancer chemotherapy. Multidrug resistant cell lines developed in vitro have provided a useful model for analyzing this phenomenon. We describe a complementary DNA, λDR11, which is present in normal cells and overexpressed in multidrug resistant cell lines. We have placed this complementary DNA in an expression vector which uses the 0-actin promoter to drive transcription and introduced this vector via transfection into drug sensitive cells. Cells expressing increased levels of XDR11 are resistant to the same broad spectrum of chemotherapeutic agents which characterize the multidrug resistant phenotype. The expression of this complementary DNA in transfected clones is dependent upon the number of copies of λDR11 integrated in the genome as well as the amount of selective pressure placed on the clone during selection of the clone. Furthermore, the number of copies of λDR11 in the genome and the expression of λDR11 can be modulated by releasing an individual clone from selective pressure or by increasing the selective pressure on the clone. The endogenous sequences encoding the multidrug resistance gene are not amplified in transfected drug resistant clones. Finally, the drug resistant phenotype is reversed in the transfected clones by verapamil just as drug resistance is reversed in multidrug resistant cell lines.

UR - http://www.scopus.com/inward/record.url?scp=0023589312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023589312&partnerID=8YFLogxK

M3 - Article

C2 - 3664502

AN - SCOPUS:0023589312

VL - 47

SP - 5982

EP - 5988

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 22

ER -